McCurnin Donald, Seidner Steven, Chang Ling-Yi, Waleh Nahid, Ikegami Machiko, Petershack Jean, Yoder Brad, Giavedoni Luis, Albertine Kurt H, Dahl Mar Janna, Wang Zheng-ming, Clyman Ronald I
Department of Pediatrics, University of Texas Health Science Center, San Antonio, Texas, USA.
Pediatrics. 2008 May;121(5):945-56. doi: 10.1542/peds.2007-2051.
The goal was to study the pulmonary, biochemical, and morphologic effects of a persistent patent ductus arteriosus in a preterm baboon model of bronchopulmonary dysplasia.
Preterm baboons (treated prenatally with glucocorticoids) were delivered at 125 days of gestation (term: 185 days), given surfactant, and ventilated for 14 days. Twenty-four hours after birth, newborns were randomly assigned to receive either ibuprofen (to close the patent ductus arteriosus; n = 8) or no drug (control; n = 13).
After treatment was started, the ibuprofen group had significantly lower pulmonary/systemic flow ratio, higher systemic blood pressure, and lower left ventricular end diastolic diameter, compared with the control group. There were no differences in cardiac performance indices between the groups. Ventilation index and dynamic compliance were significantly improved with ibuprofen. The improved pulmonary mechanics in ibuprofen-treated newborns were not attributable to changes in levels of surfactant protein B, C, or D, saturated phosphatidylcholine, or surfactant inhibitory proteins. There were no differences in tracheal concentrations of cytokines commonly associated with the development of bronchopulmonary dysplasia. The groups had similar messenger RNA expression of genes that regulate inflammation and remodeling in the lung. Lungs from ibuprofen-treated newborns were significantly drier (lower wet/dry ratio) and expressed 2.5 times more epithelial sodium channel protein than did control lungs. By 14 days after delivery, control newborns had morphologic features of arrested alveolar development (decreased alveolar surface area and complexity), compared with age-matched fetuses. In contrast, there was no evidence of alveolar arrest in the ibuprofen-treated newborns.
Ibuprofen-induced patent ductus arteriosus closure improved pulmonary mechanics, decreased total lung water, increased epithelial sodium channel expression, and decreased the detrimental effects of preterm birth on alveolarization.
本研究旨在探讨在支气管肺发育不良的早产狒狒模型中,动脉导管未闭持续存在对肺部、生化及形态学的影响。
早产狒狒(产前接受糖皮质激素治疗)于妊娠125天(足月:185天)分娩,给予表面活性剂,并通气14天。出生后24小时,将新生儿随机分为两组,一组接受布洛芬治疗(以关闭动脉导管未闭;n = 8),另一组不接受药物治疗(对照组;n = 13)。
开始治疗后,与对照组相比,布洛芬组的肺/体循环血流比值显著降低,体循环血压升高,左心室舒张末期内径减小。两组之间的心功能指标无差异。布洛芬可显著改善通气指数和动态顺应性。布洛芬治疗的新生儿肺部力学的改善并非归因于表面活性蛋白B、C或D、饱和磷脂酰胆碱或表面活性抑制蛋白水平的变化。与支气管肺发育不良发展相关的常见细胞因子的气管浓度在两组之间无差异。两组在调节肺部炎症和重塑的基因信使核糖核酸表达方面相似。布洛芬治疗的新生儿的肺组织明显更干燥(湿/干比值更低),上皮钠通道蛋白表达比对照组肺组织高2.5倍。与年龄匹配的胎儿相比,出生后14天时,对照新生儿具有肺泡发育停滞的形态学特征(肺泡表面积和复杂性降低)。相比之下,布洛芬治疗的新生儿没有肺泡停滞的证据。
布洛芬诱导的动脉导管未闭闭合改善了肺部力学,减少了肺总水量,增加了上皮钠通道表达,并降低了早产对肺泡化的有害影响。